UPS has expanded its International Special Commodities (ISC) programme in line with expanded demand for pharma shipments.
The expansion means that customers can ship biological substances, dangerous goods in excepted quantities, and shipments utilising dry ice via UPS to more than 50 additional international destinations.
This brings the total number of countries served by UPS’s dangerous goods service to more than 100.
This latest expansion is a direct response to growing demands from biopharmaceutical manufacturers, diagnostics companies, laboratories, distributors and care providers to ship specialized commodities when security, time and temperature control are a high priority.
“This network expansion demonstrates our ongoing investments to continually build out an optimized supply chain to meet our customers’ demands,” said Dan Gagnon, UPS vice president of global healthcare strategy.
“As specimen logistics get more complex globally, organizations will need to rely on streamlined, end-to-end solutions that can help transport sensitive goods on time, undamaged and within temperature range.”
Read more pharma logistics news
